Stay updated on Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial

Sign up to get notified when there's something new on the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record describes a completed Phase 2 study evaluating the safety of repeat jCell injections in adults with retinitis pigmentosa, with study details, results measures, and supporting documents.
    Difference
    46%
    Check dated 2026-11-10T18:49:59.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0 on a page displaying a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T19:12:28.000Z thumbnail image
  3. Check
    26 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces the transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision changes from v3.7.1 to v3.7.2. The study record remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T20:38:58.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T20:53:08.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    - The study page now shows a 403 Forbidden error with a simple header and a Home link, indicating that access to the page is blocked. This change reflects that the page content is no longer directly viewable in its current state.
    Difference
    17%
    Check dated 2026-09-22T22:30:53.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page shows an updated Revision tag: v3.7.0, replacing the previous v3.6.6. This indicates a newer software revision label is now displayed on the page.
    Difference
    0.1%
    Check dated 2026-09-15T21:00:11.000Z thumbnail image

Stay in the know with updates to Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Repeat Intravitreal Injection Safety in Retinitis Pigmentosa Clinical Trial page.